CYCCP
Cyclacel Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.60M
P/E Ratio
—
EPS
$-2.05
Beta
0.16
52W High
$8.50
52W Low
$3.35
50-Day MA
$5.09
200-Day MA
$5.67
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey.
Fundamentals
| Revenue (TTM) | 10,000 |
| Gross Profit (TTM) | 10,000 |
| EBITDA | $-10.36M |
| Operating Margin | -103580.00% |
| Return on Equity | -276.80% |
| Return on Assets | -102.80% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $2.29 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 960.24 |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $12.50M |
| Float | 14,640 |
| % Insiders | 1.18% |
| % Institutions | 3.55% |
Data last updated: 4/14/2026